The global enteral feeding formulas market is estimated to reach USD 5.95 Billion by 2020, growing at a CAGR of 7.6% during the forecast period. The market is mainly driven by the rising incidences of chronic diseases and disorders, the rapidly increasing geriatric population, increasing healthcare expenditure, rising prevalence of preterm births, and increasing demand for homecare.
Complete report of Enteral Feeding Formulas Market spread across 225 Pages, Profiling 11 Companies and Supported with 187 Tables and 72 Figures is now available at http://www.reportsnreports.com/reports/505777-enteral-feeding-formulas-market-by-product-polymeric-monomeric-disease-specific-formulas-by-stage-adults-pediatrics-by-application-oncology-gastroenterology-neurology-by-end-user-hospitals-ltcs-home-care-global-forecast-to-2020.html .
On the other hand, factors such as complications associated with enteral nutrition, patient safety risks, and the risk of feeding and medication errors are some factors that are expected to limit the growth of the enteral feeding formulas market in the coming years. The global enteral feeding formulas market is segmented on the basis of product, stage, application, end user, and region.
1 Market Overview
2 Asia-Pacific Market, By Application
3 Geographic Snapshot of the Market
4 North America to Dominate the Market During the Forecast Period
5 Market: Developing vs. Developed Countries
On the basis of product, the market is segmented into standard and disease-specific formulas. The standard formulas segment is further segmented into polymeric formulas and monomeric formulas. Disease-specific formulas are further subdivided into diabetic, renal, hepatic, pulmonary, and other formulas, which primarily include immune-enhancing & wound-healing formulas and formulas for critical care.
Sample Copy of this Research is Available Now
On the basis of stage, the market is segmented into adults and pediatrics. On the basis of application, the market is segmented into oncology, gastroenterology, neurology, diabetes, critical care, and other applications. Other applications primarily include diseases and disorders of the heart, renal system, lungs, and liver, along with psychiatric disorders. The oncology application segment held the largest share of the enteral feeding formulas market in 2015, primarily due to the high prevalence of malnutrition among cancer patients. By end user, the market is segmented into hospitals and long-term care facilities. Long-term care facilities are further divided into homecare agencies & hospices, nursing homes, and assisted living facilities.
The leading players in the global enteral feeding formulas market include Abbott Laboratories (U.S.), Nestlé S.A. (Switzerland), Danone S.A. (France), and Fresenius Kabi AG (Germany). Other players in this market are Mead Johnson Nutrition Company (U.S.), B. Braun Melsungen AG (Germany), Hormel Foods, LLC (U.S.), Victus Inc. (U.S.), Meiji Holdings Co., Ltd. (Japan), and Global Health Product Inc. (U.S.).
Click now for more Details, Quiries and Discount and Other Information on this study “Enteral Feeding Formulas Market by Product (Polymeric, Monomeric, Disease-Specific Formulas), by Stage (Adults, Pediatrics), by Application (Oncology, Gastroenterology, Neurology), by End User (Hospitals, LTCS, Home Care) - Global Forecast to 2020” research report can be requested at http://www.reportsnreports.com/contacts/discount.aspx?name=505777 .
The global enteral feeding formulas market is further divided into four major regions- North America, Europe, Asia-Pacific, and the Rest of the World (RoW). These regions are further analyzed at the country level. North America accounted for the largest regional market in 2015, followed by Europe, Asia-Pacific, and the RoW.
The high growth rate in this market is primarily attributed to the presence of a large patient pool for chronic diseases and disorders, increasing incidences of preterm births, growing healthcare expenditure, rapidly developing healthcare infrastructure, increasing per capita income, growing middle-class population, and a rapidly increasing population in the emerging APAC countries.
On related note another research titled "Biomarkers Market” is segmented on the basis of product, type, application, disease indication, and geography. The product segments included in this report are consumables, services, software. The type segments included in this report are safety biomarkers, efficacy biomarkers, and validation biomarkers is available at http://www.reportsnreports.com/reports/420487-cancer-biomarkers-market-by-tumor-breast-lung-prostate-type-protein-genetic-biomarkers-profiling-technology-proteomics-genomics-imaging-immunoassay-application-diagnostic-drug-discovery-prognostic-geography-global-forecast-to-2020.html
Explore more reports on Biotechnology athttp://www.reportsnreports.com/market-research/biotechnology/
ReportsandReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013